AKAN
Price
$1.37
Change
+$0.07 (+5.38%)
Updated
Jul 3 closing price
Capitalization
1.25M
HLUBF
Price
$3.70
Change
+$0.04 (+1.09%)
Updated
Apr 14 closing price
Capitalization
4.85B
Interact to see
Advertisement

AKAN vs HLUBF

Header iconAKAN vs HLUBF Comparison
Open Charts AKAN vs HLUBFBanner chart's image
Akanda
Price$1.37
Change+$0.07 (+5.38%)
Volume$23.56K
Capitalization1.25M
H. Lundbeck A/S
Price$3.70
Change+$0.04 (+1.09%)
Volume$810
Capitalization4.85B
AKAN vs HLUBF Comparison Chart in %
Loading...
AKAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLUBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKAN vs. HLUBF commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKAN is a StrongBuy and HLUBF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (AKAN: $1.37 vs. HLUBF: $3.70)
Brand notoriety: AKAN and HLUBF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AKAN: 54% vs. HLUBF: 100%
Market capitalization -- AKAN: $1.25M vs. HLUBF: $4.85B
AKAN [@Pharmaceuticals: Other] is valued at $1.25M. HLUBF’s [@Pharmaceuticals: Other] market capitalization is $4.85B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKAN’s FA Score shows that 0 FA rating(s) are green whileHLUBF’s FA Score has 1 green FA rating(s).

  • AKAN’s FA Score: 0 green, 5 red.
  • HLUBF’s FA Score: 1 green, 4 red.
According to our system of comparison, both AKAN and HLUBF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKAN’s TA Score shows that 4 TA indicator(s) are bullish while HLUBF’s TA Score has 2 bullish TA indicator(s).

  • AKAN’s TA Score: 4 bullish, 6 bearish.
  • HLUBF’s TA Score: 2 bullish, 0 bearish.
According to our system of comparison, HLUBF is a better buy in the short-term than AKAN.

Price Growth

AKAN (@Pharmaceuticals: Other) experienced а -5.52% price change this week, while HLUBF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.13%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +93.03%.

Reported Earning Dates

AKAN is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLUBF($4.85B) has a higher market cap than AKAN($1.25M). AKAN YTD gains are higher at: -14.375 vs. HLUBF (-16.479). HLUBF has higher annual earnings (EBITDA): 2.94B vs. AKAN (-3.86M). HLUBF has more cash in the bank: 2.88B vs. AKAN (3.93M). AKAN has less debt than HLUBF: AKAN (3.83M) vs HLUBF (5.22B). HLUBF has higher revenues than AKAN: HLUBF (18.9B) vs AKAN (111K).
AKANHLUBFAKAN / HLUBF
Capitalization1.25M4.85B0%
EBITDA-3.86M2.94B-0%
Gain YTD-14.375-16.47987%
P/E RatioN/A11.95-
Revenue111K18.9B0%
Total Cash3.93M2.88B0%
Total Debt3.83M5.22B0%
TECHNICAL ANALYSIS
Technical Analysis
AKANHLUBF
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
25%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
32%
Advances
ODDS (%)
Bullish Trend 8 days ago
85%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AKAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLUBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FLUX1.950.16
+8.94%
Flux Power Holdings
KRNY6.950.12
+1.76%
Kearny Financial Corp
CCK107.900.99
+0.93%
Crown Holdings
EPAC38.050.06
+0.16%
Enerpac Tool Group Corp
ALCYU11.41N/A
N/A
Alchemy Investments Acquisition Corp

AKAN and

Correlation & Price change

A.I.dvisor tells us that AKAN and SCYX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AKAN and SCYX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKAN
1D Price
Change %
AKAN100%
+5.38%
SCYX - AKAN
30%
Poorly correlated
+1.57%
SNOA - AKAN
25%
Poorly correlated
+1.71%
TLRY - AKAN
25%
Poorly correlated
+11.03%
SNDL - AKAN
24%
Poorly correlated
+1.60%
ACB - AKAN
23%
Poorly correlated
+1.57%
More

HLUBF and

Correlation & Price change

A.I.dvisor tells us that HLUBF and HLBBF have been poorly correlated (+18% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HLUBF and HLBBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLUBF
1D Price
Change %
HLUBF100%
N/A
HLBBF - HLUBF
18%
Poorly correlated
N/A
HLNCF - HLUBF
7%
Poorly correlated
-5.74%
ESAIY - HLUBF
5%
Poorly correlated
+0.28%
AKAN - HLUBF
2%
Poorly correlated
+5.38%
HLN - HLUBF
1%
Poorly correlated
-0.10%
More